NCT06272565View on ClinicalTrials.gov

Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage

Not yet recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

July 3, 2024

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Diabetic RetinopathyDiabetic Macular EdemaAnti-vascular Endothelial Growth Factor
Trial Locations (1)

510623

Zhongshan Ophthalmic Center of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER

NCT06272565 - Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage | Biotech Hunter | Biotech Hunter